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Abstract
Objective: To test the hypothesis that a functional polymorphism of the serotonin transporter 
gene (serotonin-transporter-linked polymorphic region [5-HTTLPR]), which is thought to be 
associated with differential environmental sensitivity, moderates the association between low 
levels of empathic accuracy (i.e., ability to recognize emotions in others) in patients with 
neurodegenerative disease and caregivers’ well-being.
Methods: Participants were 54 patients with neurodegenerative disease and their caregivers. 
Patients’ empathic accuracy was measured using a dynamic tracking task in which they 
continuously rated the emotions of a character in a film; accuracy was determined by comparing 
Send correspondence and reprint requests to Robert W. Levenson, Ph.D., Department of Psychology, University of California, 2121 
Berkeley Way, Room 3302, Berkeley, CA 94720-1650. boblev@berkeley.edu. 
SUPPLEMENTARY MATERIALS
Supplementary material associated with this article can be found in the online version at https://doi.org/10.1016/j.jagp.2019.04.009.
HHS Public Access
Author manuscript
Am J Geriatr Psychiatry. Author manuscript; available in PMC 2019 October 01.
Published in final edited form as:
Am J Geriatr Psychiatry. 2019 October ; 27(10): 1046–1056. doi:10.1016/j.jagp.2019.04.009.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
patient ratings with those made by an expert panel. Caregivers provided a saliva sample for 
genotyping. Caregivers’ well-being was measured as a latent construct indicated by validated 
measures of depression, anxiety, and negative affect.
Results: Lower levels of patients’ empathic accuracy were associated with lower levels of 
caregivers’ well-being. Importantly, caregivers’ 5-HTTLPR genotype moderated this association 
such that lower empathic accuracy in patients predicted lower well-being for caregivers with the 
short/short genotype (standardized β = 0.66), but not for caregivers with the short/long 
(standardized β = 0.66) or long/long genotypes (standardized β = 0.66).
Conclusion: Consistent with previous findings that the short/short variant of 5-HTTLPR is 
associated with greater sensitivity to environmental influences, caregivers with the short/short 
variant manifest lower well-being when caring for a patient with low levels of empathic accuracy 
than caregivers with the other variants. This finding contributes to the authors’ understanding of 
biological factors associated with individual differences in caregiver vulnerability and resilience.
Keywords
Caregiver; depression; anxiety; empathic accuracy; 5-HTTLPR; gene-environment interaction
INTRODUCTION
Neurodegenerative diseases are incurable, debilitating conditions that result in deficits in 
cognitive, emotional, and motor functioning. With increasing incidence of these diseases, the 
number of close loved ones serving as caregivers is rising dramatically.1 Compared with 
non-caregiving adults and nondementia caregivers, caregivers of patients with dementia have 
considerably lower well-being.2,3 Not all caregivers experience similar declines in well-
being. Therefore, it is important to identify the factors accounting for caregivers’ 
vulnerability and resilience.
Research implicates a number of factors associated with greater vulnerability to the adverse 
outcomes of caregiving: personality traits, such as neuroticism;4 demographic or external 
factors, including inadequate financial or social support;4 and patients’ behavioral and 
psychological symptoms, such as a lack of empathy.4 Indeed, emerging consensus from the 
literature suggests that patients’ behavioral and psychological symptoms are even worse for 
caregiver burden and health than patients’ cognitive or functional impairments.5–7 In 
particular, deficits in empathy have emerged as an important source of caregiver 
vulnerability.
Empathy is critical for close relationships. Having a more empathically accurate close 
relational partner is associated with lower depression,8 and patients with more empathic 
therapists and physicians often have better mental and physical health outcomes.9,10 
Empathy is particularly important for those in high stress contexts in which social support is 
needed (such as caregiving). For example, a study using caregiver report of patient empathy 
found that lower patient empathy was related to poor relationship quality between the patient 
and caregiver.11 Moreover, patients with lower empathic accuracy (who are less able to track 
others’ changing emotions) have caregivers who experience greater burden, strain, 
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loneliness, and depressive symptoms.6 These findings suggest patients’ inability to 
recognize and respond to others’ changing emotions may be particularly devastating for 
caregivers.
Important individual differences may exist in the ways that caregivers respond to 
environmental risk factors. Caregivers with genetic variations associated with heightened 
sensitivity to environmental influences may be more impacted by patients’ empathic 
accuracy deficits. A series of studies using a candidate gene approach has shown that short 
allele carriers of the serotonin-transporter-linked polymorphic region (5-HTTLPR) 
polymorphism manifest greater sensitivity to both positive and negative aspects of their 
environment. Examples include heightened amygdala reactivity to negative faces,12 greater 
empathic responding to distressing stimuli,13 and increased positive emotional expressions 
to amusing stimuli.14
Early studies on 5-HTTLPR demonstrated an association between the short allele and 
heightened risk for depression, anxiety, and suicide in the face of adversity.15 Findings from 
this approach were met with controversy, as replication issues arose and meta-analyses 
concluded that the 5-HTTLPR by environment interaction did not predict depression.16 
However, more recent meta-analyses have found support for this prediction.17 These 
findings support hypotheses that caregivers who are 5-HTTLPR short allele carriers would 
be more sensitive to the negative stresses of patients’ empathic accuracy deficits, leading to 
worse outcomes for those caregivers.
The present study investigates whether caregivers’ 5-HTTLPR genotypemoderates the 
association between patients’ empathic accuracy and caregivers’ well-being. We 
hypothesized that caregivers with two copies of the short allele of 5-HTTLPR would be at 
greater risk for lowest levels of well-being when caring for a patient with lower empathic 
accuracy, compared with caregivers with the other genotypes. To our knowledge, this study 
is the first to investigate this relationship.
METHODS
Participants
Patients with neurodegenerative disease and their caregivers (N dyads = 54) were recruited 
from the Memory and Aging Center at the University of California, San Francisco (UCSF). 
Patients were evaluated at UCSF and diagnosed based on current consensus criteria.18–23 
The sample included patients with frontotemporal dementia, Alzheimer disease, 
neurodegenerative diseases that impact motor functioning, and those at high risk for a 
neurodegenerative disease (e.g., mild cognitive impairment). Caregivers were predominantly 
spouses, and all self-identified as playing a primary role in providing care to the patient. 
Demographic characteristics of patients and caregivers are presented in Table 1.
Procedure
Patients underwent detailed neurologic, neuropsy-chological, and neuroimaging assessments 
at UCSF. Within 3 months of their UCSF visit, patients and caregivers came to the Berkeley 
Psychophysiology Laboratory at the University of California, Berkeley. Informed consent 
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was obtained from both patients and caregivers. All procedures were approved by the 
University of California, Berkeley Committee for Protection of Human Subjects. Patients 
completed emotional functioning tasks,24 including an objective measure of empathic 
accuracy.6,25 Caregivers completed questionnaires and provided a saliva sample for genetic 
testing.
Patient Empathic Accuracy
Apparatus and procedures—Patients sat in front of a television monitor with a rating 
dial located near their dominant hand. The dial consisted of a small metal box with a rotating 
pointer that traversed a 180° path. The path overlaid a 9-point scale anchored by the legends 
“very bad” on the left, “neutral” in the middle, and “very good” on the right. Patients moved 
the rating dial continuously to reflect the feelings of a target character in an 80-second film 
clip, which depicted an actress experiencing a range of positive and negative emotions. 
Patients demonstrated that they understood the instructions. During the task, a voltage was 
generated reflecting the dial position; a computer sampled the voltage every 3 milliseconds 
and computed the average dial position for every second.
Accuracy score calculation—Empathic accuracy was calculated using time-lagged 
cross-correlations between each patient’s ratings and those obtained from an expert panel of 
healthy individuals. To allow for differences in information processing and motoric speed 
that is common in neurodegenerative disease, the maximum correlation coefficient was 
selected for lags between −10 and +10 seconds.
Clinical Measures for Patients and Caregivers
Patient disease severity—At UCSF, the Clinical Dementia Rating Scale was completed 
using a semi-structured interview by clinicians,26 assessing functional performance in six 
domains: memory, orientation, judgment and problem-solving, community affairs, home and 
hobbies, and personal care. For each domain, a score was given ranging from 0 (none) to 3 
(severe) based on a description of functioning. Scores were summed across domains to 
create a score (Clinical Dementia Rating Scale Box Score), ranging from 0–18. Higher 
scores indicated greater disease severity.
Caregiver well-being—Caregiver well-being was conceptualized as a latent variable 
indicated by low levels of depressive symptoms, anxiety symptoms, and negative affect.
Caregiver depression—Caregivers’ depressive symptoms for the past week were 
assessed using the Center for Epidemiologic Studies Depression Scale27 20-item 
questionnaire. Caregivers rated themselves on a 4-point scale from 0 (rarely or none of the 
time) to 3 (most or all of the time) for each item (e.g., “I felt lonely”). Four items were 
reverse scored, then all items were summed. Higher scores indicated greater levels of 
depressive symptoms.
Caregiver anxiety—Caregivers’ anxiety symptoms were assessed using the Beck Anxiety 
Inventory,28 a 21-item questionnaire. Caregivers rated themselves on a 4-point scale from 0 
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(not at all) to 3 (severely) for each symptom (e.g., “unable to relax”). Scores were summed. 
Higher scores indicated greater levels of anxiety symptoms.
Caregiver affect—Caregivers’ trait positive and negative affect were assessed using the 
Positive and Negative Affect Schedule,29 a 20-item questionnaire that evaluates levels of 
positive affect (e.g., enthusiastic, interested, determined) and negative affect (e.g., scared, 
afraid, upset). Caregivers rated the extent to which they experienced each of 20 emotions in 
the past month on a 5-point scale from 1 (very slightly or not at all) to 5 (extremely). Scores 
were summed, with higher scores indicating greater levels of affect. Four caregivers did not 
complete one item on the Positive and Negative Affect Schedule. For them, scores were 
imputed by taking the average of the nine completed items and multiplying that value by 10.
Caregiver 5-HTTLPR Genotyping
Caregivers were invited to participate in a DNA assessment during the laboratory session. 
DNA were collected and extracted from saliva using Oragene kits (DNA Genotek, Kanata, 
Ontario, Canada) according to manufacturer’s protocol. Anonymized DNA samples were 
extracted and purified by Creative Genomics (Port Jefferson Station, NY). The extracted 
DNA were genotyped at the University of California, Los Angeles. Amplification was 
performed using the AccuPrime Taq High Fidelity DNA Polymerase kit (Invitrogen, 
Carlsbad, California). The reaction contained a 6-FAM labeled forward primer (/56-FAM/
GGCGTTGCCGCTCTGAATGC) and a reverse primer 
(GAGGGACTGAGCTGGACAACCA).30 The polymerase chain reactions were then sent 
for fragment analysis on an AB3730XL with a LIZ1200 size standard. Data quality was 
assessed by duplicating a sub-set of random DNA samples; genotype data reproducibility 
was 100%. The genotyping yielded three groups, individuals with two short alleles (S/S; n= 
14), one short and one long allele (S/L; n = 26), or two long alleles (L/L; n= 14). This 
genotype distribution was consistent with previous studies and did not deviate from Hardy-
Weinberg equilibrium: χ2(1) = 0.07; p = 0.791. The 5-HTTLPR genotype was coded using 
an additive coding scheme (1 = L/L, 2 = S/L, and 3 = S/S), as in previous studies.13,15
Analytic Plan
First, we conducted bivariate correlations to evaluate associations between patients’ 
empathic accuracy and dementia severity, and caregivers’ depression, anxiety, negative 
affect, and positive affect (Table 2). In addition, we evaluated internal consistency among the 
indicators of well-being and tested for main effects among the indicator variables as a 
function of caregiver genotype groups.
Structural equation modeling analyses proceeded in three steps. First, we used confirmatory 
factor analyses (CFA) to test a measurement model of caregiver wellbeing, a latent variable 
indicated by caregivers’ depressive symptoms, anxiety symptoms, and negative affect, using 
the lavaan package in R software version 3.3.1 (R Foundation for Statistical Computing, 
Vienna, Austria). Next, we created a path model with patient empathic accuracy predicting 
caregiver well-being and used multi-group modeling to examine whether caregivers’ 5-
HTTLPR genotype moderated this association. We report standardized β and z-statistic 
(similar to t-statistic in linear regression) for these associations, which are measures of effect 
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size. Finally, we probed the stability of the findings when controlling for patients’ dementia 
severity and caregivers’ age, sex, and race.
Nonsignificant χ2 values (ps >0.05) indicated satisfactory model fit. We also inspected the 
comparative fit index (CFI) and standardized root mean square of residual (SRMR), 
following established guidelines.31 For CFI, values greater than 0.90 indicated reasonable fit 
and values greater than 0.95 indicated good fit. For SRMR, values less than 0.08 indicated 
good fit.
To rule out the possibility that observed effects were driven by individuals at “high risk” for 
a neuro-degenerative disease, we repeated the structural equation modeling analyses, 
removing those with mild cognitive impairment diagnoses and primary relatives of patients 
with frontotemporal dementia (Supplementary Tables S1–S3).
RESULTS
Preliminary Analyses
The Pearson correlations revealed that lower patients’ empathic accuracy was associated 
with greater caregivers’ depression (r =−0.31; p = 0.021), anxiety (r =−0.29; p = 0.036), and 
negative affect (r =−0.26; p = 0.060). Patients’ empathic accuracy was not associated with 
caregivers’ positive affect (r = 0.11; p = 0.45), consistent with its exclusion from the well-
being latent construct. As expected, patients’ empathic accuracy and dementia severity were 
also correlated (r =−0.41; p = 0.002).
Next, we examined reliability among caregivers’ depressive symptoms, anxiety symptoms, 
and negative affect. Reliability was high (Cronbach’s α = 0.89), supporting the possibility 
that the observed scores for these variables are influenced by an underlying, latent construct.
We also tested whether there were significant differences in caregivers’ levels of depression, 
anxiety, and negative affect across genotype groups. Using the Levene test, we found that 
there was inequality in the variances of caregivers’ depressive symptoms (but not the other 
measures) across genotype groups. The Kruskal-Wallis one-way analysis of variance (a 
nonparametric method that allows for heteroskedasticity) revealed no differences in 
caregivers’ depressive symptoms and one-way analysis of variance revealed no differences 
in caregivers’ anxiety symptoms and negative affect across caregivers’ genotype groups 
(Table 1).
Structural Equation Modeling
We used CFA to test a measurement model of caregiver well-being, indicated by caregivers’ 
depressive symptoms, anxiety symptoms, and negative affect. For clarity of interpretation, 
we reversed the directions of the factor loadings (such that greater loadings of depression, 
anxiety, and negative affect reflect lower well-being). In the initial CFA, the residual 
variance for caregivers’ negative affect was not significantly different from zero (δ = 0.079; 
p = 0.26). The χ2 analyses comparing a measurement model with caregivers’ negative affect 
residual variance fixed to zero to the initial measurement model (without negative affect 
residual variance fixed to zero) demonstrated that the models were not significantly different 
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(Δχ2(1) = 1.15; p = 0.28). Therefore, we repeated the CFA, fixing the residual variance for 
caregivers’ negative affect to zero. The CFA for caregiver well-being indicated excellent fit: 
χ2(1) = 1.15; p = 0.28; CFI = 1.00; SRMR= 0.02.
Subsequent analyses showed that a structural equation model (Fig. 1) with patient empathic 
accuracy as a predictor of caregiver well-being had excellent fit: χ2(3) = 3.82; p = 0.28; CFI 
= 0.99; SRMR = 0.05. Factor loadings and residual variances are reported in Table 3.
Multi-Group Modeling
Next, we examined whether the inclusion of 5-HTTLPR genotype groups improved model 
fit using multi-group modeling (i.e., by comparing a model in which the association between 
patients’ empathic accuracy and caregivers’ well-being was constrained to be equal across 
caregiver 5-HTTLPR genotype variants to a model in which this association was not 
constrained using Δχ2 tests). Results showed that including caregivers’ 5-HTTLPR 
genotype group significantly improved model fit: Δχ2(2) = 8.76; p = 0.013. The multi-group 
model also indicated excellent fit, χ2(9) = 9.30; p = 0.41; CFI = 1.00; SRMR = 0.04.
Consistent with our hypothesis, 5-HTTLPR moderated the association between patient 
empathic accuracy and caregiver well-being. Specifically, lower patient empathic accuracy 
predicted lower caregiver well-being—only for those with the short/short genotype (β = 
0.66; z = 2.81; p = 0.002)—but not for those with the short/long (β =0.05; z = 0.23; p = 
0.82) or long/long (β = −0.21; z = −0.79; p = 0.44) genotypes. These associations are 
depicted in Figure 2, and the simple correlations for each genotype group show the same 
pattern of findings (Supplementary Table S4).
Finally, we probed the stability of the results by controlling for patients’ dementia severity 
and caregivers’ age, sex (coded 0 = female, 1 = male), and race (coded 0 = non-white, 1= 
white). Multi-group modeling revealed that including caregivers’ 5-HTTLPR genotype 
significantly improved model fit: Δχ2(2) = 7.96; p = 0.019. Overall, the multi-group model 
with the addition of these covariates indicated suboptimal fit: χ2(33) = 66.37; p = 0.001; CFI 
= 0.80; SRMR = 0.08. Again, patient empathic accuracy was positively associated with 
caregiver well-being for those with the short/short genotype (β = 0.47; z = 2.21; p = 0.018), 
but not for those with the short/long (β = 0.07; z = 0.52; p = 0.61) or long/long (β = −0.28; z 
= −1.07; p = 0.30) genotypes.
DISCUSSION
The present study sought to increase understanding of individual differences in caregiver 
well-being by evaluating the influence of caregivers’ 5-HTTLPR genotype on their 
vulnerability to patients’ empathic accuracy deficits. We measured patients’ empathic 
accuracy objectively through a dynamic tracking task and used this measure to predict 
caregivers’ well-being as indicated by measures of depression, anxiety, and negative affect. 
We explored differences in this relationship across caregivers’ 5-HTTLPR genotypes.
Findings revealed a significant positive relationship between patients’ empathic accuracy 
and caregivers’ well-being for caregivers with the short/short genotype (even after 
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controlling for caregivers’ age, sex, and race and patients’ dementia severity), but not for 
caregivers with the short/long and long/long genotypes. Given the study’s relatively small 
sample size and the inclusion of multiple covariates in the model, independent replication 
will be necessary before these results can be considered conclusive. Nevertheless, these 
findings provide preliminary evidence that caregivers with the short/short genotype may be 
at heightened risk for low well-being when caring for a patient with neurodegenerative 
disease who has deficits in empathic accuracy. To our knowledge, this is the first study to 
identify a specific genetic polymorphism that may play a role in moderating the association 
between patient deficits and caregiver outcomes.
Our results are consistent with prior work suggesting that the short/short 5-HTTLPR 
genotype acts as a susceptibility factor to environmental stimuli, amplifying negative 
outcomes in negative contexts12 (i.e., stressful caregiving environment) and positive 
outcomes in positive contexts.14 Given this bidirectional sensitivity, one might expect 
caregivers with short/short to be particularly healthy (i.e., high well-being) when caring for a 
patient with high empathic accuracy. However, because neurodegenerative disease 
overwhelmingly produces declines in patient functioning, associated environmental effects 
will pre-dominately be reflected in negative outcomes.
Prior research has documented short allele carriers’ heightened sensitivity both on distal or 
long-term measures (e.g., psychopathology and marital satisfaction)15,32 as well as on more 
proximal measures (e.g., reactivity to an emotional stimulus).13,14 Extending this model 
further, heightened emotional reactivity may be a proximal mechanism through which the 
short allele contributes to distal out-comes.33 Longitudinal studies are needed to test whether 
caregivers’ heightened negative emotional reactivity (a proximal mechanism), perhaps in 
response to patients’ increasing empathic accuracy deficits, mediates the relationship 
between caregivers’ genotype and changes in caregivers’ well-being over time (a distal 
outcome).
It is also important to understand the biological basis of caregivers’ vulnerability. The short 
allele is associated with lower levels of serotonin uptake and lower transcriptional efficiency 
of the serotonin transporter protein.34 It has been argued that increased available synaptic 
serotonin in short allele carriers may result in increased amygdala excitability to external 
stimuli,12 which may result in heightened emotional reactivity. The efficiency of the 
serotonin system has been shown to decline with age both in terms of central serotonin 
transporter availability and postsynaptic serotonin receptors.35 Therefore, it is possible that 
the effects of serotonin-related genes such as 5-HTTLPR are magnified with age, which may 
shed light on how this single allele could have such a powerful effect in our sample of older 
adults. Although brain imaging data were not collected in this study, white matter pathology 
has been similarly implicated in the stress exposure-outcome pathway in caregivers.36 
Future studies that evaluate multiple pathways could disentangle the relative contributions of 
these mechanisms to caregivers’ increased vulnerability.
Implications
Patients’ empathic accuracy deficits may render them incapable of identifying and therefore 
responding to others’ emotions. When patients’ empathic accuracy declines and caregivers 
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lose a vital source of social support, caregivers with the short/short genotype might feel 
particularly lonely and isolated. If these findings replicate, they suggest that evaluating 
caregivers’ genotype in conjunction with patient deficits may facilitate identification of 
caregivers at greatest risk for low well-being. These caregivers may be good candidates for 
preventative interventions and supportive resources, such as emotion regulation skills (to 
mitigate heightened emotional reactivity) or referrals to caregiver support groups (to address 
feelings of loneliness). There are also important implications for pharmacological 
interventions. Short allele carriers show promising response and remission rates for 
depression treatment using selective serotonin reuptake inhibitors.37 Additional work is 
needed to clarify the specific biological pathways through which selective serotonin 
reuptake inhibitors may mitigate depressive symptoms for short allele carriers. In light of 
recent evidence showing that low levels of mental health in caregivers are associated with 
greater patient mortality,38 the implications of these findings are important for patients and 
caregivers alike.
Strengths and Limitations
Strengths of this study include the dyadic design and a specific measure of stress. Previous 
research on 5-HTTLPR has typically studied individual participants and assessed overall 
levels of stress without regard to the particular contributing stressors (e.g., stressful life event 
checklist).17 In addition, patients’ empathic accuracy was measured objectively and 
separately from the caregiver; therefore, we reduced common method variance that could 
inflate found associations.
There are also important limitations to note. Our sample size (N = 54 dyads) was small by 
the standards of candidate gene studies.39 Therefore, the results should be interpreted 
cautiously awaiting future replication in larger samples. A larger sample size would also 
have enabled us to detect possible codominant effects of the 5-HTTLPR alleles (i.e., 
differences between one and two long alleles). In addition, it will be important to evaluate 
the boundary conditions of these findings, such as whether they are generalizable across all 
types of caregiving relationships (e.g., professional caregivers, friends) and other types of 
patient deficits in emotional functioning (e.g., problems with emotion regulation).
In general, candidate gene approaches have been met with criticism.16 Our decision to focus 
on 5-HTTLPR as a candidate genetic vulnerability factor in caregivers was based on 
documented biological pathways linking 5-HTTLPR and well-being (with 5-HTTLPR 
encoding a direct target for antidepressant medication)37 and well-established links between 
5-HTTLPR and heightened reactivity to emotional stimuli.12–14,32 Other approaches (e.g., 
genome-wide association studies) have clear benefits, although we note that they typically 
do not assess tandem repeat genetic variants, such as 5-HTTLPR.40
CONCLUSION
Caregiving can exact a heavy toll, but there is huge variability in how caregivers react to the 
challenges of caregiving. As the number of older adults in the population rises, there is an 
urgent need to identify factors that contribute to individual differences in caregiver 
outcomes. Evaluating the role of specific patient deficits (e.g., empathic accuracy) in the 
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context of caregiver vulnerabilities (e.g., 5-HTTLPR polymorphism) provides valuable 
information regarding which caregivers are susceptible to a particular kind of environmental 
stressor. Future research should continue to examine the pathways through which genes 
interact with the social environment to alter caregivers’ quality of life. Uncovering patient 
and caregiver factors that undermine caregiver well-being will be critical for developing 
effective interventions that promote the health of caregivers and the patients in their care.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1. 
Structural equation model with patient empathic accuracy predicting caregiver well-being.
*
 N.E. = not estimated; fixed to 0
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FIGURE 2. 
Simple slopes and 95% confidence intervals by 5-HTTLPR genotype group.
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